Loading the security page…
A security analysis is not yet prepared for this market.
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Eledon Pharmaceuticals, Inc. (ELDN) is a company in the Health care sector; its shares trade on Nasdaq.
Eledon Pharmaceuticals, Inc. trades on Nasdaq under the ticker ELDN. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks ELDN has traded between 1.35 $ and 4.60 $. As of 30 October 2026 the price stood 27.69 % of the way from the 52-week low to the high.
Over one year ELDN shares fell 16.97 %; over six months they fell 31.82 %. Volatility over 90 days is 51.79 %. Dividends are not included: this is price change only, as of 30 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 6.8, above the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
ELDN has a return on equity of −298.55 %, below the sector median of −40.58 %. Return on assets is −78.16 %, below the sector median of −30.08 %.